Fresenius Medical Care Announces Presentation Of First Results From…

Main Category: Urology / Nephrology Also Included In: Clinical Trials / Drug Trials Article Date: 12 Nov 2009 Fresenius Medical Care, the world’s largest provider of dialysis products and services, announces the presentation of the first results from the CALcium acetate MAGnesium carbonate evaluation study for the new phosphate binder OsvaRen at …

source : www.topix.com

Related News:

• First measurement of energy released from a virus during infection
• Vaccine to protect pregnant women from contracting malaria?
• PROLOR Biotech Reports Positive Top-Line Results From Phase I Study Of Its Longer-Acting Version Of Human Growth Hormone
• A Statement From Johns Hopkins Medicine About Hela Cells And Their Use
• Highlights From February Ophthalmology
• News From The Journal Of Clinical Investigation: Feb. 1, 2010
• Repros Receives Guidance From FDA Regarding Continued Development Of Androxal(R) In Hypogonadal Men
• Chronic Sinusitis Sufferers Benefit From Surgery
• Grant To Study How Cells Sense Electric Fields
• American Academy Of Dermatology Lauds U.S. Federal Trade Commission For Protecting The Public From False Health And Safety Claims About Indoor Tanning

Details :
Submited at Thursday, November 12th, 2009 at 7:00 pm on Urology by chuck
Comment RSS 2.0 - leave a comment - trackback